Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001455859-10-000008
Filing Date
2010-10-29
Accepted
2010-10-29 16:40:52
Documents
1
Period of Report
2010-10-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6298
  Complete submission text file 0001455859-10-000008.txt   8297
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS BIOTECHNOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 855 N. WOLFE STREET, SUITE 619 BALTIMORE MD 21205
Business Address
Morris Ronnie (Reporting) CIK: 0001504443 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 101152341